GLENMEDE TRUST CO NA - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q1 2020$03,9250.0%0.00%
Q4 2019$03,9250.0%0.00%
Q3 2019$03,9250.0%0.00%
Q2 2019$03,9250.0%0.00%
Q1 2019$03,9250.0%0.00%
Q4 2018$03,9250.0%0.00%
Q3 2017$03,9250.0%0.00%
Q2 2017$03,9250.0%0.00%
Q1 2017$03,9250.0%0.00%
Q4 2016$03,9250.0%0.00%
Q3 2016$0
-100.0%
3,9250.0%0.00%
Q2 2016$1,0003,9250.0%0.00%
Q1 2016$0
-100.0%
3,9250.0%0.00%
Q4 2015$6,000
-14.3%
3,9250.0%0.00%
Q3 2015$7,000
-22.2%
3,9250.0%0.00%
Q2 2015$9,000
-47.1%
3,9250.0%0.00%
Q1 2015$17,000
-5.6%
3,9250.0%0.00%
Q4 2014$18,000
+12.5%
3,9250.0%0.00%
Q3 2014$16,000
-30.4%
3,9250.0%0.00%
Q2 2014$23,0003,9250.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q4 2015
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$19,322,0007.71%
First Washington CORP 185,250$771,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 194,200$808,0000.10%
KINGDON CAPITAL MANAGEMENT, L.L.C. 286,801$1,173,0000.05%
EMERALD ADVISERS, LLC 175,000$728,0000.04%
Pine River Capital Management L.P. 209,900$873,0000.01%
Alyeska Investment Group, L.P. 79,196$329,0000.01%
HighTower Advisors, LLC 66,514$277,0000.01%
Tower Research Capital LLC (TRC) 1,441$6,0000.00%
First Eagle Investment Management, LLC 114,456$476,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders